Literature DB >> 15615762

Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.

J B Jonas, I Kreissig, R F Degenring, B A Kamppeter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15615762      PMCID： PMC1772464          DOI： 10.1136/bjo.2004.050575

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

Authors:  Jost B Jonas; Imren Akkoyun; Wido M Budde; Ingrid Kreissig; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2004-02

2.  Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.

Authors:  Paul M Beer; Sophie J Bakri; Ravinder J Singh; Weiguo Liu; George B Peters; Michael Miller
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

3.  Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  Intravitreal triamcinolone for refractory diabetic macular edema.

Authors:  Adam Martidis; Jay S Duker; Paul B Greenberg; Adam H Rogers; Carmen A Puliafito; Elias Reichel; Caroline Baumal
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

5.  Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Robert F Degenring; Bernd A Kamppeter; Ingrid Kreissig; Imren Akkoyun
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258
  5 in total
  5 in total

1.  Intravitreal triamcinolone therapy for diabetic macular oedema.

Authors:  S A Vernon
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

2.  Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

Authors:  J B Jonas; I Akkoyun; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

3.  Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema.

Authors:  C K M Chan; S Mohamed; M P Shanmugam; C-W Tsang; T Y Y Lai; D S C Lam
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

4.  Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

Authors:  U H M Spandau; M Derse; P Schmitz-Valckenberg; C Papoulis; J B Jonas
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

Review 5.  Clinical trials on corticosteroids for diabetic macular edema.

Authors:  Hassan A Al Dhibi; J Fernando Arevalo
Journal:  World J Diabetes       Date:  2013-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.